Publications - 'P'
Publications 326 - 350 de 2458
| Titre | DOI |
|---|---|
|
Payment Vs. Compensation For Ecosystem Services: Do Words Have A Voice In The Design of Environmental Conservation Programs? S. Clot; G. Grolleau; P. Meral 2017 |
10.1016/j.ecolecon.2016.12.028 |
|
Pazopanib (P) and cisplatin (CDDP) in patients with advanced solid tumors: A UNICANCER phase I study. V. Dieras; T. Bachelot; M. Campone; N. Isambert; F. Joly; C. Le Toumeau; P.Alexandre Cassler; E. Bompas; P. Fumoloau; S. Noal; C. Orsini; M. Jimenez; D.Charlotte Imbs; E. Chatelut 2014 |
10.1200/jco.2014.32.15_suppl.2583 |
|
Pazopanib in patients with progressive recurrent or metastatic (R/M) salivary gland carcinoma (SGC): Further evaluation of efficacy including tumor growth rates (GR) analysis. H&N Unicancer Group PACSA trial with the REFCOR J. Guigay; F. Bidault; J. Fayette; C. Even; D. Cupissol; F. Rolland; F. Peyrade; B. Laguerre; C. Le Tourneau; S. Zanetta; B. Le Moal; C. Borel; L. Digue; J. Delaye; S. Diffetocq; V. Costes; A. Auperin; L. Faivre 2016 |
10.1093/annonc/mdw376.38 |
|
Pazopanib or methotrexate-vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 study M. Toulmonde; M. Pulido; I. Ray-Coquard; T. Andre; N. Isambert; C. Chevreau; N. Penel; E. Bompas; E. Saada; F. Bertucci; C. Lebbe; A. Le Cesne; P. Soulie; S. Piperno-Neumann; S. Sweet; F. Cecchi; T. Hembrough; C. Bellera; M. Kind; A. Crombe; C. Lucchesi; F. Le Loarer; J.Y. Blay; A. Italiano 2019 |
10.1016/S1470-2045(19)30276-1 |
|
Pazopanib plus best supportive care versus best supportive care alone in advanced gastrointestinal stromal tumours resistant to imatinib and sunitinib (PAZOGIST): a randomised, multicentre, open-label phase 2 trial O. Mir; C. Cropet; M. Toulmonde; A. Le Cesne; M. Molimard; E. Bompas; P. Cassier; I. Ray-Coquard; M. Rios; A. Adenis; A. Italiano; O. Bouche; E. Chauzit; F. Duffaud; F. Bertucci; N. Isambert; J. Gautier; J.Y. Blay; D. Perol; G.S.F. -GETO 2016 |
10.1016/S1470-2045(16)00075-9 |
|
PCA-Based Visual Servoing Using Optical Coherence Tomography B. Dahroug; B. Tamadazte; N. Andreff 2020 |
10.1109/LRA.2020.2977259 |
|
pCONus Device for the Endovascular Treatment of Wide-Neck Middle Cerebral Artery Aneurysms B. Gory; M. Aguilar-Perez; E. Pomero; F. Turjman; W. Weber; S. Fischer; H. Henkes; A. Biondi 2015 |
10.3174/ajnr.A4392 |
|
PCR ITS-RFLP for Penicillium Species and Other Genera S. Rousseaux; M. Guilloux-Benatier 2017 |
10.1007/978-1-4939-6707-0_21 |
|
PCSK9 inhibitors: What place in the management of dyslipidemia? P. Sabouret; M. Farnier; E. Puymirat 2019 |
10.1016/j.lpm.2019.01.009 |
|
PCSK9 levels do not predict severity and recurrence of cardiovascular events in patients with acute myocardial infarction M. Zeller; G. Lambert; M. Farnier; M. Maza; B. Nativel; L. Rochette; C. Vergely; Y. Cottin 2021 |
10.1016/j.numecd.2020.11.010 |
|
PCTOC, 40 years on: an anniversary editorial S. Ochatt 2021 |
10.1007/s11240-021-02088-1 |
|
Pd(0)-Catalyzed Amination in the Synthesis of Bicyclic Compounds Comprising Triazacycloalkane and Fluorophore Moieties A.D. Averin; N.M. Chernichenko; V.N. Shevchuk; O.A. Maloshitskaya; F. Denat; I.P. Beletskaya 2018 |
10.6060/mhc171255a |
|
PD-1 and TIGIT co-expression identifies a circulating CD8 T cell population predictive of response to anti-PD-1 therapy in melanoma and Merkel-cell carcinoma patients S. Simon; V. Voillet; V. Vignard; Z. Wu; C. Dabrowski; N. Jouand; T. Beauvais; A. Khammari; C. Braudeau; R. Josien; O. Adotevi; C. Laheurte; F. Aubin; C. Nardin; S. Rulli; R. Gottardo; N. Ramchurren; C. Martin; S.P. Fling; C.D. Church; P. Nghiem; B. Dreno; S.R. Riddell; N. Labarriere 2020 |
10.1158/1538-7445.AM2020-4476 |
|
PD-1 and TIGIT coexpression identifies a circulating CD8 T cell subset predictive of response to anti-PD-1 therapy S. Simon; V. Voillet; V. Vignard; Z. Wu; C. Dabrowski; N. Jouand; T. Beauvais; A. Khammari; C. Braudeau; R. Josien; O. Adotevi; C. Laheurte; F. Aubin; C. Nardin; S. Rulli; R. Gottardo; N. Ramchurren; M. Cheever; S.P. Fling; C.D. Church; P. Nghiem; B. Dreno; S.R. Riddell; N. Labarriere 2020 |
10.1136/jitc-2020-001631 |
|
PD-1/PD-L1 Checkpoints and Resveratrol: A Controversial New Way for a Therapeutic Strategy D. Delmas; F. Hermetet; V. Aires 2021 |
10.3390/cancers13184509 |
|
PD-1/PD-L1 pathway: an adaptive immune resistance mechanism to immunogenic chemotherapy in colorectal cancer M. Dosset; T.Rivera Vargas; A. Lagrange; R. Boidot; F. Vegran; A. Roussey; F. Chalmin; L. Dondaine; C. Paul; E.Lauret Marie-Joseph; F. Martin; B. Ryffel; C. Borg; O. Adotevi; F. Ghiringhelli; L. Apetoh 2018 |
10.1080/2162402X.2018.1433981 |
|
Pd-Catalyzed Amination in the Synthesis of a New Family of Macropolycyclic Compounds Comprising Diazacrown Ether Moieties A.A. Yakushev; N.M. Chernichenko; M.V. Anokhin; A.D. Averin; A.K. Buryak; F. Denat; I.P. Beletskaya 2014 |
10.3390/molecules19010940 |
|
Pd-Cu catalysts supported on anion exchange resin for the simultaneous catalytic reduction of nitrate ions and reductive dehalogenation of organochlorinated pollutants from water C. Bradu; C. Capat; F. Papa; L. Frunza; E.A. Olaru; G. Crini; N. Morin-Crini; E. Euvrard; I. Balint; I. Zgura; C. Munteanu 2019 |
10.1016/j.apcata.2018.11.002 |
|
PD-L1 and IL17 expression in tumor infiltrating lymphocytes are opposite prognostic factors in glioblastoma E. Bronsart; V. Derangere; M. Boone; B. Chauffert; F. Ghiringhelli 2016 |
10.1093/annonc/mdw367.5 |
|
PD-L1 expression is regulated by both DNA methylation and NF-kappa B during EMT signaling in non-small cell lung carcinoma A. Asgarova; K. Asgarov; Y. Godet; P. Peixoto; A. Nadaradjane; M. Boyer-Guittaut; J. Galaine; D. Guenat; V. Mougey; J. Perrard; J.R. Pallandre; A. Bouard; J. Balland; C. Tirole; O. Adotevi; E. Hendrick; M. Herfs; P.F. Cartron; C. Borg; E. Hervouet 2018 |
10.1080/2162402X.2017.1423170 |
|
PD-L1 in circulating exosomes of Merkel cell carcinoma A. Zanella; V. Vautrot; F. Aubin; L. Avoscan; M. Samimi; C. Garrido; J. Gobbo; C. Nardin Submitted |
10.1111/exd.14520 |
|
Pd-Polypyrrole Nanocomposite in Environmentally Friendly Synthesis of Vinylnitriles Using K4Fe(CN)(6) T.V. Magdesieva; O.M. Nikitin; O.V. Polyakova; P.K. Sazonov; E.V. Zolotukhina; K.V. Gor'kov; A.V. Samarov; M.A. Vorotyntsev 2018 |
10.1002/slct.201800657 |
|
Pd-PPy nanocomposite on the surface of carbon nanotubes: synthesis and catalytic activity K.V. Gor'kov; N.V. Talagaeva; J.C. Hierso; I.S. Bezverkhyy; P.A. Pisareva; M. Vorotyntsev; E.V. Zolotukhina 2017 |
10.1680/jsuin.17.00016 |
|
PDL1-expressing circulating tumor cells (CTCs) in head and neck squamous cell carcinoma (HNSCC). G. Koutsodontis; A. Strati; M. Avgeris; E. Maratou; V. Ramfidis; G. Konstantinidis; P. Economopoulou; G. Kotsantis; K. Tsigaridas; E.Mihal Vagia; N. Haralambakis; C. Sasaki; A. Scorilas; C. Perisanidis; M. Vasilakopoulou; A. Strimpakos; E. Lianidou; A. Psyrri 2015 |
10.1200/jco.2015.33.15_suppl.6018 |
|
PDMS membranes modified by polyelectrolyte multilayer deposition to improve OSN separation of diluted solutes in toluene M. Morshed; A. Zimmer; L. Broch; H. Alem; D. Roizard 2020 |
10.1016/j.seppur.2019.116331 |